/

Fosaprepitant

Overview

Fosaprepitant is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved for medical use in the United States, and in the European Union in January 2008

Anant Labs manufacture and furnish high quality Fosaprepitant impurities for global markets. Our Fosaprepitant EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Fosaprepitant

Fosaprepitant

Mol. Formula: C₂₃H₂₂F₇N₄O₆P
Mol. Weight: 614.411

Impurities (5)

Chemical structure of Aprepitant Impurity 1 Enantiomer HCl

Aprepitant Impurity 1 Enantiomer HCl

Cat. No.: ANT-FSP-004
CAS: 171482-05-6
Mol. Formula: C₂₀H₁₉ClF₇NO₂
Mol. Weight: 473.82

Chemical structure of Aprepitant Process Impurity 3

Aprepitant Process Impurity 3

Cat. No.: ANT-FSP-005
CAS: 155742-64-6
Mol. Formula: C₄H₈ClN₃O₂
Mol. Weight: 165.58

Chemical structure of Dibenzyl Phosphate Impurity

Dibenzyl Phosphate Impurity

Cat. No.: ANT-FSP-003
CAS: 1623-08-1
Mol. Formula: C₁₄H₁₅O₄P
Mol. Weight: 278.24

Chemical structure of Fosaprepitant Dimeglumine

Fosaprepitant Dimeglumine

Cat. No.: ANT-FSP-02
CAS: 265121-04-8
Mol. Formula: C₃₇H₅₆F₇N₆O₁₆P
Mol. Weight: 1004.84

Chemical structure of Fosaprepitant Dimeglumine Aprepitant Impurity

Fosaprepitant Dimeglumine Aprepitant Impurity

Cat. No.: ANT-FSP-01
CAS: 170729-80-3
Mol. Formula: C₂₃H₂₁F₇N₄O₃
Mol. Weight: 534.43